Janssen Sciences, a a subsidiary of Johnson & Johnson, announced an expansion of its Irish facility located in Cork that will allow it to meet the critical needs of patients around the world.
The expansion plans involve an investment of more than €300 million that will increase the existing manufacturing space by an additional 19,100m2, provide employment for up to 450 people during construction and an extra 200 people once completed.
Kyran Johnson, General Manager, Janssen Supply Chain Ireland, said “this expansion project is a significant vote of confidence in our team and one which will increase our manufacturing footprint very significantly, allowing us to continue to meet critical patient needs in the areas of Multiple Myeloma, Rheumatoid Arthritis and Crohn’s Disease.”
Janssen Sciences Ireland UC has operated a biopharmaceutical supply chain facility on its 40 hectare site in Ringaskiddy since 2005.
The proposed expansion project includes the following elements: construction of a new manufacturing building, expansion of the existing warehouse building, laboratory and administration buildings, modification of expansion of other aspects of the existing site and infrastructure and expansion of the on-site waste water treatment plant to accommodate increased volumes.
Construction on the Janssen Sciences Ireland UC expansion is expected to take approximately two years, beginning in October 2017.